Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Alexander

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Gut|June 2, 2026
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of GastroenterologyJames L Alexander, Benjamin H Mullish, Linda Thomas, et al.
Inflammatory Bowel Diseases|November 6, 2020
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile InfectionJessica R Allegretti, Colleen R Kelly, Ari Grinspan, et al.
Gut Microbes|July 18, 2025
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohortShiva T Radhakrishnan, Benjamin H Mullish, Marton L Olbei, et al.
Microbiome|May 9, 2023
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancerJames L Alexander, Joram M Posma, Alasdair Scott, et al.
The Journal of Clinical Investigation|April 20, 2021
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinomaDaria Capece, Daniel D'Andrea, Federica Begalli, et al.
Gut|February 8, 2023
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome researchJames L Alexander, Nicola J Wyatt, Stephane Camuzeaux, et al.
Ebiomedicine|January 12, 2023
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patientsJames L Alexander, Benjamin H Mullish, Nathan P Danckert, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
BMJ Open|February 9, 2023
Trajectory of knee health in runners with and without heightened osteoarthritis risk: the TRAIL prospective cohort study protocolDanilo De Oliveira Silva, Richard T R Johnston, Benjamin F Mentiplay, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Gut|June 2, 2026
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of GastroenterologyJames L Alexander, Benjamin H Mullish, Linda Thomas, et al.
Inflammatory Bowel Diseases|November 6, 2020
Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile InfectionJessica R Allegretti, Colleen R Kelly, Ari Grinspan, et al.
Gut Microbes|July 18, 2025
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohortShiva T Radhakrishnan, Benjamin H Mullish, Marton L Olbei, et al.
Microbiome|May 9, 2023
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancerJames L Alexander, Joram M Posma, Alasdair Scott, et al.
The Journal of Clinical Investigation|April 20, 2021
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinomaDaria Capece, Daniel D'Andrea, Federica Begalli, et al.
Gut|February 8, 2023
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome researchJames L Alexander, Nicola J Wyatt, Stephane Camuzeaux, et al.
Ebiomedicine|January 12, 2023
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patientsJames L Alexander, Benjamin H Mullish, Nathan P Danckert, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
BMJ Open|February 9, 2023
Trajectory of knee health in runners with and without heightened osteoarthritis risk: the TRAIL prospective cohort study protocolDanilo De Oliveira Silva, Richard T R Johnston, Benjamin F Mentiplay, et al.
Pageof 6